HUTCHMED (China) Limited (AIM:HCM)
216.00
0.00 (0.00%)
Oct 16, 2026, 4:35 PM GMT
HUTCHMED (China) Stock Forecast
Stock Price Forecast
According to 7 analysts polled by S&P Global, HUTCHMED (China) stock has a consensus rating of "Buy" and an average price target of 344p. The average 1-year stock price forecast is 59.20% higher than the current stock price, while the lowest is 221p (+2.36%) and the highest is 531p (+145.86%).
Price Target: 344p (+59.20%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on Sep 8, 2026.
Analyst Ratings
The average analyst rating for HUTCHMED (China) stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 2 | 2 | 2 | 2 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HSBC | HSBC | Buy Upgrades 167p | Buy | Upgrades | 167p | -22.70% | Sep 8, 2026 |
Unknown Analyst CICC No rating | CICC | Buy Maintains 249p → 269p | Buy | Maintains | 249p → 269p | +24.39% | Sep 8, 2026 |
Unknown Analyst Huatai Securities No rating | Huatai Securities | Buy Maintains 315p → 321p | Buy | Maintains | 315p → 321p | +48.78% | Sep 7, 2026 |
Unknown Analyst Citic Securities No rating | Citic Securities | Buy Maintains 345p → 365p | Buy | Maintains | 345p → 365p | +68.82% | Sep 7, 2026 |
Unknown Analyst Citi No rating | Citi | Buy Maintains 374p | Buy | Maintains | 374p | +73.26% | Sep 3, 2026 |
Financial Forecast
Revenue This Year
626.61M
from 548.51M
Increased by 14.24%
Revenue Next Year
698.80M
from 626.61M
Increased by 11.52%
EPS This Year
0.06
from 0.52
Decreased by -88.31%
EPS Next Year
0.07
from 0.06
Increased by 14.39%
EPS and Forward PE are based on non-GAAP adjusted numbers.